Members |
targetComponentId |
Benign neoplasm of skin of trunk, excluding scrotum |
Benign neoplasm of skin of trunk |
Benign neoplasm of skin of upper limb and shoulder |
Benign neoplasm of skin of shoulder |
Benign neoplasm of skin of upper limb and shoulder |
Benign neoplasm of skin of upper limb |
Benign neoplasm of skull (& [facial bones]) |
Benign neoplasm of skull and facial bones |
Benign neoplasm of skull (& [facial bones]) |
Benign neoplasm of face bone |
Benign neoplasm of small intestine and duodenum |
Benign neoplasm of small intestine |
Benign neoplasm of small intestine and duodenum |
Benign neoplasm of duodenum |
Benign neoplasm of spine: [vertebral column excluding sacrum and coccyx] or [vertebra] |
Benign neoplasm of vertebral column, excluding sacrum and coccyx |
Benign neoplasm of spine: [vertebral column excluding sacrum and coccyx] or [vertebra] |
Benign neoplasm of bone structure of spine (disorder) |
Benign neoplasm of stomach |
Gastric polyp |
Benign neoplasm of stomach |
Benign neoplasm of stomach |
Benign neoplasm of thyroid gland |
Thyroid adenoma |
Benign neoplasm of thyroid gland |
Benign neoplasm of thyroid gland |
Benign neoplasm of: [central nervous system] or [brain and other parts of nervous system] |
Benign neoplasm of central nervous system |
Benign neoplasm of: [central nervous system] or [brain and other parts of nervous system] |
Benign neoplasm of nervous system |
Benign neoplasm of: [liver and biliary ducts] or [biliary system] |
Benign neoplasm of liver and/or biliary ducts (disorder) |
Benign neoplasm of: [liver and biliary ducts] or [biliary system] |
Benign neoplasm of biliary tract |
Benign neoplasm of: [nose, middle ear and accessory sinuses] or [nasal sinus] |
Benign neoplasm of accessory sinus |
Benign neoplasm of: [vocal fold] or [glottis] |
Benign neoplasm of vocal cord |
Benign neoplasm: [lip] or [oral cavity] or [pharynx] |
Benign neoplasm of lip, oral cavity and pharynx |
Benign neoplasm: [lip] or [oral cavity] or [pharynx] |
Benign neoplasm of oral cavity (disorder) |
Benign neoplasm: [lip] or [oral cavity] or [pharynx] |
Benign neoplasm of mouth region (disorder) |
Benign neoplasm: [lip] or [oral cavity] or [pharynx] |
Benign neoplasm of pharynx |
Benign osseous and chondromatous tumour morphology |
Osseous AND/OR chondromatous neoplasm (morphologic abnormality) |
Benign paroxysmal positional vertigo or nystagmus |
Benign paroxysmal positional vertigo |
Benign paroxysmal positional vertigo or nystagmus |
Nystagmus due to benign paroxysmal positional vertigo |
Benign pemphigus |
Familial benign pemphigus |
Benign pemphigus |
Pemphigus |
Benign pinealoma |
Pinealoma |
Benign thyroid tumour: [adenoma] |
Thyroid adenoma |
Benign thyroid tumour: [adenoma] |
Benign neoplasm of thyroid gland |
Benign thyroid tumour: [adenoma] |
Thyroid adenoma |
Benign tumor of head and neck |
Benign neoplasm of neck |
Benign tumor of head and neck |
Benign neoplasm of head |
Benign tumor of pituitary and hypothalamus |
Benign neoplasm of hypothalamus (disorder) |
Benign tumor of pituitary and hypothalamus |
Benign neoplasm of pituitary gland |
Benign tumor of unknown origin or ill-defined site |
Benign neoplasm of unknown origin (disorder) |
Benign tumor of unknown origin or ill-defined site |
Benign neoplastic disease (disorder) |
Benorylate 2g/5mL s/f suspension |
Benorilate 400 mg/mL oral suspension |
Benserazide + levodopa adverse reaction |
Adverse reaction to benserazide and/or levodopa (disorder) |
Bent bone dysplasia |
FGFR2-related bent bone dysplasia is a rare, genetic, lethal, primary bone dysplasia characterized by dysmorphic craniofacial features (low-set, posteriorly rotated ears, hypertelorism, megalophthalmos, flattened and hypoplastic midface, micrognathia), hypomineralization of the calvarium, craniosynostosis, hypoplastic clavicles and pubis, and bent long bones (particularly involving the femora), caused by germline mutations in the FGFR2 gene. Prematurely erupted fetal teeth, osteopenia, hirsutism, clitoromegaly, gingival hyperplasia, and hepatosplenomegaly with extramedullary hematopoiesis may also be associated. |
Bent bone dysplasia |
Bent bone dysplasia group |
Bent grass pollen allergen |
Bent grass pollen |
Benzene causing toxic effect |
Toxic effect of petroleum ether |
Benzene causing toxic effect |
Toxic effect of benzene AND/OR homologue |
Benzhexol hydrochloride 5mg/5mL syrup |
Trihexyphenidyl hydrochloride 1 mg/mL oral solution |
Benzimidazole anthelmintic adverse reaction |
Adverse reaction to benzimidazole |
Benzimidazole with anthelmintic mechanism of action |
Benzimidazole (substance) |
Benzimidazole with anthelmintic mechanism of action |
Anthelmintic |
Benzodiazepine sedative adverse reaction |
Adverse reaction to benzodiazepine |
Benzoic acid and salicylic acid |
Benzoic acid (substance) |
Benzoic acid and salicylic acid |
Salicylic acid (substance) |
Benzoic and salicylic acid ointment |
Salicylic acid (substance) |
Benzoic and salicylic acid ointment |
Benzoic acid (substance) |
Benzoyl peroxide 10% cream |
Benzoyl peroxide 100 mg/mL cutaneous cream |
Benzoyl peroxide 2.5% aqueous gel |
Product containing precisely benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Benzoyl peroxide 2.5% gel |
Product containing precisely benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Benzoylmethylecgonine |
Cocaine (substance) |
Benzoylmethylecgonine measurement |
Cocaine measurement |
Benzydamine hydrochloride 0.15% oral rinse |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
Benzypyrinium |
Benzpyrinium (substance) |
Beractant 200mg/8mL suspension |
Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) |
Berardinelli lipodystrophy syndrome |
Congenital total lipodystrophy (disorder) |
Berger's immunoglobulin A or immunoglobulin G nephropathy |
IgA nephropathy |
Bergeyella species |
Bergeyella |
Berlesiella species |
Capronia |
Bermuda grass pollen allergen |
Bermuda grass pollen |
Besnoitia species |
Besnoitia |
Bespoke shoes |
Bespoke shoes |
Best ever peak flow rate |
Best ever peak flow rate (respiratory) |
Best ever peak flow rate |
Best ever peak expiratory flow rate |
Beta thalassaemia trait |
Beta thalassaemia trait |
Beta thalassaemia trait |
Heterozygous thalassemia |
Beta thalassaemia: (& minor) |
Beta thalassemia |
Beta-glucuronidase test |
MUG test |
Beta-glucuronidase test |
Beta-glucuronidase measurement |
Beta-hydroxyisobutyryl-coenzyme A deacylase deficiency |
Disease with characteristics of delayed motor development, hypotonia and progressive neurodegeneration. To date, it has been described in four boys. The syndrome is caused by mutations affecting the two alleles of the HIBCH gene, encoding 3-hydroxyisobutyryl-CoA hydrolase which is caused by homozygous or compound heterozygous mutation in the HIBCH gene on chromosome 2q32. |
Betamethasone + antimicrobials |
Antibacterial |
Betamethasone + antimicrobials |
Betamethasone |
Betamethasone 4mg/mL injection solution 1mL ampule |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Betamethasone valerate 0.12% foam |
Betamethasone valerate 1.2 mg/mL cutaneous foam |
Betamethasone valerate systemic preparation |
Betamethasone-containing product in parenteral dose form |
Better eye: low vision, Lesser eye: profound visual impairment |
Blind right eye |
Better eye: low vision, Lesser eye: profound visual impairment |
Bilateral visual impairment (disorder) |
Better eye: low vision, Lesser eye: profound visual impairment |
Severe visual impairment (disorder) |
Better eye: low vision, Lesser eye: profound visual impairment |
Blind left eye |
Better eye: low vision, Lesser eye: profound visual impairment |
Moderate visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: blind, unspecified |
Bilateral visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: blind, unspecified |
Moderate visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: blind, unspecified |
Blind right eye |
Better eye: moderate visual impairment, Lesser eye: blind, unspecified |
Blind left eye |
Better eye: moderate visual impairment, Lesser eye: moderate visual impairment |
Bilateral visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: moderate visual impairment |
Moderate visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: near total visual impairment |
Severe visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: near total visual impairment |
Moderate visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: near total visual impairment |
Bilateral visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: profound visual impairment |
Bilateral visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: profound visual impairment |
Severe visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: profound visual impairment |
Moderate visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: severe visual impairment |
Severe visual impairment (disorder) |
Better eye: moderate visual impairment, Lesser eye: severe visual impairment |
Bilateral visual impairment (disorder) |